Analyst Reco. U.S. Physical Therapy, Inc.

Equities

USPH

US90337L1089

Market Closed - Nyse Other stock markets 21:00:02 26/04/2024 BST			5-day change	1st Jan Change
100.6 ^USD	+0.23%		+1.53%	+8.02%

04-01	U.S. Physical Therapy, Inc. acquired 50% stake in Nine-Clinic Physical Therapy And Hand Therapy Practice for $16.4 million.	CI
03-13	JPMorgan Adjusts U.S. Physical Therapy's Price Target to $117 From $99, Reiterates Overweight Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JPMorgan Adjusts U.S. Physical Therapy's Price Target to $117 From $99, Reiterates Overweight Rating	03-13	MT
Barrington Ups Price Target on U.S. Physical Therapy to $122 From $120 After Strong Q4 Beat, Keeps Outperform Rating	03-01	MT
Barrington Adjusts Price Target on U.S. Physical Therapy to $120 From $111, Maintains Outperform Rating	01-03	MT
JPMorgan Adjusts Price Target on U.S. Physical Therapy to $99 From $108, Maintains Overweight Rating	11-17	MT
Barrington Cuts Price Target on U.S. Physical Therapy to $111 From $124 on 'Tough Stock Market Environment', Reiterates Outperform Rating	11-09	MT
JPMorgan Starts US Physical Therapy at Overweight With $108 Price Target	22/09/23	MT
CJS Securities Upgrades US Physical Therapy to Market Outperform From Market Perform, $120 Price Target	19/09/23	MT
Jefferies Adjusts U.S. Physical Therapy Price Target to $130 From $145, Maintains Buy Rating	15/09/23	MT
Barrington Boosts Price Target on U.S. Physical Therapy to $124 From $116, Keeps Outperform Rating	14/08/23	MT
BofA Securities Initiates U.S. Physical Therapy With Buy Rating, $138 Price Target	30/06/23	MT
Barrington Research Adjusts Price Target on U.S. Physical Therapy to $110 From $107, Maintains Outperform Rating	24/02/23	MT
Barrington Research Lowers U.S. Physical Therapy's Price Target to $107 From $123, Maintains Outperform Rating	05/08/22	MT
Barrington Research Trims US Physical Therapy's Price Target to $123 From $144, Maintains Outperform Rating	25/02/22	MT
Barrington Adjusts Price Target on US Physical Therapy to $144 From $142, Maintains Outperform Rating	03/01/22	MT
CJS Securities Upgrades U.S. Physical Therapy to Outperform From Market Perform, Lower Price Target to $120 From $126	14/12/21	MT
Barrington Adjusts Price Target on US Physical Therapy to $142 From $139 on Long-Term Confidence, Maintains Outperform Rating	10/12/21	MT
Sidoti Upgrades U.S. Physical Therapy to Buy From Neutral, Keeps $124 Price Target	22/11/21	MT
U S PHYSICAL THERAPY : Barrington Adjusts Price Target on U.S. Physical Therapy to $139 From $130 After 'Exceptionally Strong Q2', Maintains Outperform Rating	06/08/21	MT
U S PHYSICAL THERAPY : Barrington Research Upgrades U.S. Physical Therapy to Outperform From Market Perform, $130 Price Target	07/05/21	MT
U S PHYSICAL THERAPY : Barrington Research Downgrades US Physical Therapy to Market Perform From Outperform; Removes $116 Price Target	26/02/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. U.S. Physical Therapy, Inc.

Equities

USPH

US90337L1089

Analyst Reco.

Filters